Eris Lifesciences Quarterly Results for Trading Insights
ERIS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹135 Cr
QSept 2025
Eris Lifesciences Quarterly Results Key Highlights
- Revenue of ₹793 Cr in Sept 2025 (+11.5% vs Mar 2025, +6.6% vs Sept 2024)
- Net Profit of ₹135 Cr in Sept 2025 (+32.4% vs Mar 2025, +40.6% vs Sept 2024)
- EBITDA of ₹289 Cr in Sept 2025 (+12.0% vs Mar 2025)
- Operating Margin of 36.0% in Sept 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹8.82 in Sept 2025 (+27.8% vs Mar 2025)
Eris Lifesciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 793 | 711 | 775 | 744 | 562 | 11.5% | 6.6% |
| Net Profit (₹ Cr) | 135 | 102 | 125 | 96 | 80 | - | - |
| EBITDA (₹ Cr) | 289 | 258 | 279 | 267 | 160 | - | - |
| EPS (₹) | 8.82 | 6.90 | 8.66 | 6.73 | 5.22 | - | - |
| Operating Margin (%) | 36.0% | 36.0% | 36.0% | 35.0% | 26.0% | - | - |
Eris Lifesciences Share Price Trend Around Quarterly Results
Visualize Eris Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in Eris Lifesciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Eris Lifesciences
Additional stock information and data for ERIS
Revenue Trend (₹ Cr)
Sept 2024
744
Jun 2025
775
Mar 2025
711
Sept 2025
793
Net Profit Trend (₹ Cr)
Sept 2024
96
Jun 2025
125
Mar 2025
102
Sept 2025
135
Operating Margin Trend (%)
Sept 2024
35.0%
Jun 2025
36.0%
Mar 2025
36.0%
Sept 2025
36.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Eris Lifesciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores